Immediate Impact

2 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

TRAPT: a multi-stage fused deep learning framework for predicting transcriptional regulators based on large-scale epigenomic data
2025 Standout
Atopic dermatitis
2025 Standout
3 intermediate papers

Works of Mai Kato being referenced

The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-co
2015
Phase 2a, randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study of a H4R‐antagonist (JNJ‐39758979) inJapanese adults with moderate atopic dermatitis
2014
and 1 more

Author Peers

Author Last Decade Papers Cites
Mai Kato 223 145 17 347 317 41 1.1k
T Ogawa 112 271 21 101 179 33 1.0k
Tomonobu Ito 237 324 64 215 327 54 1.4k
Tej Pratap Singh 161 173 49 274 94 27 967
Anita Remitz 222 156 29 856 115 48 1.2k
Αthanasios Mavropoulos 71 230 47 109 115 39 967
Juan Cheng 156 329 132 95 163 46 1.2k
Robert J. Wills 36 157 72 57 181 39 969
Chih-Hao Wu 150 313 87 52 122 60 1.2k
Hyun‐Jin An 41 229 33 170 99 38 978
Xiaoming Zhang 79 367 115 90 192 60 1.3k

All Works

Loading papers...

Rankless by CCL
2026